BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11850299)

  • 1. Photodynamic therapy for age-related macular degeneration.
    Franks W
    Age Ageing; 2002 Jan; 31(1):5-6. PubMed ID: 11850299
    [No Abstract]   [Full Text] [Related]  

  • 2. Photodynamic therapy in age-related macular degeneration: missing information.
    Wenkstern A; Stokes J
    Age Ageing; 2003 May; 32(3):357-9. PubMed ID: 12720631
    [No Abstract]   [Full Text] [Related]  

  • 3. [Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration].
    Augustin AJ
    Krankenpfl J; 2000 Oct; 38(9-10):342-3. PubMed ID: 11194354
    [No Abstract]   [Full Text] [Related]  

  • 4. Photodynamic therapy with verteporfin (Visudyne) for macular degeneration.
    Med Lett Drugs Ther; 2000 Sep; 42(1086):81-2. PubMed ID: 10980812
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement after verteporfin therapy.
    Anand R; Bressler NM; Bressler SB; Gray TE; Harvey P; Haynes L; Koester JM; Manos KS; Miller JW; Murphy S; Reaves A; Sickenberg M; Singerman LJ; Strong A; Stur M;
    Arch Ophthalmol; 2003 Mar; 121(3):415-6. PubMed ID: 12617718
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on photodynamic therapy in age-related macular degeneration.
    Rechtman E; Ciulla TA; Criswell MH; Pollack A; Harris A
    Expert Opin Pharmacother; 2002 Jul; 3(7):931-8. PubMed ID: 12083992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using light to treat age-related macular degeneration.
    Nosek J
    Nurs Times; 2005 Nov 15-21; 101(46):30-3. PubMed ID: 16315801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne).
    Mandal N; Chisholm IH
    Br J Ophthalmol; 2002 Jan; 86(1):118-9. PubMed ID: 11801521
    [No Abstract]   [Full Text] [Related]  

  • 10. Ophthaproblem. Photodynamic therapy with verteporfin.
    Sharma S
    Can Fam Physician; 2001 May; 47():955, 963. PubMed ID: 11398726
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.
    Aggio FB; Melo GB; Höfling-Lima AL; Eid Farah M
    Acta Ophthalmol Scand; 2006 Dec; 84(6):831-3. PubMed ID: 17083553
    [No Abstract]   [Full Text] [Related]  

  • 12. Can [symbol: see text] verteporfin help in macular degeneration?
    Drug Ther Bull; 2001 Apr; 39(4):30-2. PubMed ID: 11329798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
    Harding S
    Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394
    [No Abstract]   [Full Text] [Related]  

  • 14. Photodynamic therapy for age-related macular degeneration: a candid appraisal.
    Sternberg P; Lewis H
    Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872
    [No Abstract]   [Full Text] [Related]  

  • 15. Photodynamic therapy for age-related macular degeneration.
    Beck RW
    Am J Ophthalmol; 2004 Sep; 138(3):513; author reply 513-4. PubMed ID: 15364257
    [No Abstract]   [Full Text] [Related]  

  • 16. Using intravenous diphenhydramine to minimize back pain associated with photodynamic therapy with verteporfin.
    Tornambe PE
    Arch Ophthalmol; 2002 Jun; 120(6):872. PubMed ID: 12049608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Photodynamic therapy and age-related macular degeneration in 2000].
    Desmettre T; Cohen SY; Mordon S
    J Fr Ophtalmol; 2001 Jan; 24(1):82-93. PubMed ID: 11240477
    [No Abstract]   [Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin: a new treatment in ophthalmology.
    Michels S; Schmidt-Erfurth U
    Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
    Bressler NM; Bressler SB; Haynes LA; Hao Y; Kaiser PK; Miller JW; Naor J; Potter MJ; Pournaras CJ; Reaves A; Rosenfeld PJ; Schmidt-Erfurth U; Slakter JS; Strong A; Vannier S
    Arch Ophthalmol; 2005 Sep; 123(9):1283-5. PubMed ID: 16157822
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
    Soubrane G; Bressler NM
    Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.